A 87,000 sq ft of state-of-the-art flexible laboratory and office space, the announcement strengthens the hub’s growing community of healthcare innovators and highlights its role in supporting collaboration, growth and clinical excellence.

Panthera, which recruits patients and runs clinical trials for pharmaceutical and biotech companies and the seven largest Contract Research Organisations (CROs), is currently based within the Clinical Innovation Zone (CIZ) at Queen Elizabeth University Hospital. The move to the Health Innovation Hub will allow Panthera to expand its operations, increase capacity and offer more opportunities for people in Glasgow to take part in clinical research.

This follows the news of digital chemistry company Chemify joining the roster of HiH alongside the Digital Health Validation Lab (DHVL). DHVL provides essential infrastructure and expertise to support innovators in building the evidence needed to guide decisions at critical points, including investment, regulatory approval, and market access.

HiH is Glasgow’s new purpose-built life science facility focused on advancing precision medicine technologies through the R&D stage ahead of commercialisation. This flagship investment is being delivered and operated by Kadans Science Partner, in collaboration with The Living Laboratory for Precision Medicine, a University of Glasgow-led programme that is at the forefront of translating cutting-edge science and innovation into real-world clinical settings.

Mark Hanna, director of asset management for Kadans Science Partner, said: “This is a historic moment for Glasgow and indeed the life science ecosystem in Scotland as the Health Innovation Hub will be a catalyst for healthcare innovation.

“Its location breathes new life into the area and being on the doorstep of the Queen Elizabeth University Hospital and the University of Glasgow’s Clinical Innovation Zone, offers unparalleled access to world-leading academics and outstanding clinical infrastructure and resources.”

Dr Ruth McLaughlin, programme director for the Living Laboratory programme, added: “Set to become a cornerstone of Scotland’s healthcare innovation ecosystem, Health Innovation Hub will play a vital role in pioneering new solutions to some of today’s most pressing healthcare challenges, offering a collaborative environment where innovative ideas can move seamlessly from R&D through to commercialisation.

“It’s fantastic to see the first tenants being announced, including Chemify and Panthera, as HiH begins to build a vibrant community of innovators and collaborators who are looking to make a lasting impact on healthcare.”

Stuart Young, CEO at Panthera, said: “We are delighted to be moving into this new centre of excellence as we expand our state of the art clinic to meet growing demand from our Sponsors and patients.

£This move will enable us to increase the number of people from Glasgow taking part in clinical trials, giving them access to cutting-edge treatments for life-changing conditions, years before they become widely available through the NHS.”